Stephens reissued their overweight rating on shares of Natera (NASDAQ:NTRA – Free Report) in a research note published on Tuesday, Benzinga reports. Stephens currently has a $78.00 target price on the medical research company’s stock. Several other brokerages have also recently commented on NTRA. Piper Sandler reduced their price objective on shares of Natera from […]
Torray Investment Partners LLC raised its stake in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 3.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 20,775 shares of the medical research company’s stock after buying an additional 749 shares […]
Stephens reiterated their overweight rating on shares of Natera (NASDAQ:NTRA – Free Report) in a research report released on Tuesday, Benzinga reports. Stephens currently has a $78.00 price target on the medical research company’s stock. A number of other equities research analysts also recently weighed in on the stock. Piper Sandler lowered their target price […]
Harvest Fund Management Co. Ltd acquired a new stake in Natera, Inc. (NASDAQ:NTRA – Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 1,001 shares of the medical research company’s stock, valued at approximately $44,000. Several other hedge funds and other institutional investors […]
Natera, Inc. (NASDAQ:NTRA – Get Free Report) insider John Fesko sold 2,358 shares of the business’s stock in a transaction on Monday, January 29th. The shares were sold at an average price of $65.09, for a total transaction of $153,482.22. Following the sale, the insider now owns 108,494 shares in the company, valued at approximately […]